Article Information
History
- March 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Andrew Siderowfa,†,#,
- Luis Concha-Marambiob,†,
- David-Erick Lafontantc,
- Carly M. Farrisb,
- Yihua Mab,
- Paula A. Ureniab,
- Hieu Nguyenb,
- Roy N. Alcalayd,e,
- Lana M. Chahinef,
- Tatiana Foroudg,
- Douglas Galaskoh,
- Karl Kieburtzi,
- Kalpana Merchantj,
- Brit Mollenhauerk,
- Kathleen L. Postonl,
- John Seibylm,
- Tanya Simunij,
- Caroline M. Tannern,o,
- Daniel Weintraubp,q,
- Aleksandar Videnovicr,
- Seung Ho Choic,
- Ryan Kurthc,
- Chelsea Caspell-Garciac,
- Christopher S. Coffeyc,
- Mark Frasiers,
- Luis M. A. Oliveiras,
- Samantha J. Hutten5,
- Todd Sherers,
- Kenneth Marekm,
- Claudio Sotob,t,# and
- the Parkinson’s Progression Markers Initiative††
- aDepartment of Neurology, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, USA
- bR&D Unit, Amprion Inc., San Diego, CA, USA
- cDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA
- dDepartment of Neurology, Tel Aviv Sourasky Medical Center, Israel
- eDepartment of Neurology, Columbia University Irving Medical Center, NY, USA
- fDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
- gDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
- hDepartment of Neurology, University of California, San Diego, California, USA
- iUniversity of Rochester Medical Center, University of Rochester, Rochester, NY, USA
- jDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- kDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany; Paracelsus-Elena Klinik, Kassel and Scientific Employee with an Honorary Contract at German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
- lDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
- mInstitute for Neurodegenerative Disorders, New Haven, Connecticut, USA
- nDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA
- oParkinson’s Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
- pDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- qParkinson’s Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
- rDepartment of Neurology, Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- sThe Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
- tDepartment of Neurology, University of Texas McGovern Medical School at Houston, Texas, USA
- ↵#Corresponding authors:
Dr. Andrew Siderowf and Dr. Claudio Soto (Claudio.Soto{at}uth.tmc.edu)
↵† These authors contributed equally to this manuscript
Posted March 01, 2023.
Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study
